Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Prana Biotechnology was established to commercialise research into Alzheimer’s disease and other major age-related neurodegenerative disorders. The company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including the University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, discovered Prana’s technology. ( www.pranabio.com )
Prana Biotechnology Limited
Principal Office Level 2 369 Royal Parade
Parkville, Victoria 3052
Australia
Tel: +61 3 9349 4906
Fax: +61 3 9348 0377